8-KThe WireRoutine
Reg FD Disclosure
Filed Apr 25, 2023 · 3y ago · Accession 0001193125-23-114750
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Acrivon Therapeutics, Inc.
- Ticker
- ACRV
- CIK
- 1781174
- Form type
- 8-K
- Filing date
- Apr 25, 2023
- Report date
- Apr 25, 2023
- Document
- d482869d8k.htm
- Size
- 14.5 MB